The basal-bolus regimens with multiple daily injections or insulin pump in addition to the educational programs such as flexible insulin therapy (FIT) were recommended as the optimum therapy for the patient with type 1 diabetes to achieve better glycemic control and prevent microvascular complications (nephropathy, neuropathy, and retinopathy) [1, 2]. This evidence concerns the gene INS and type 1 diabetes mellitus.